Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul:42:102204.
doi: 10.1016/j.msard.2020.102204. Epub 2020 May 16.

COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile

Ethel Ciampi  1 , Reinaldo Uribe-San-Martin  2 , Claudia Cárcamo  3
Affiliations

COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile

Ethel Ciampi et al. Mult Scler Relat Disord. 2020 Jul.
No abstract available

Keywords: COVID-19; Multiple sclerosis; Telemedicine.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest EC received the ECTRIMS Clinical Fellowship (2013-2014), ECTRIMS travel grant awards, and academic travel support from Novartis, Genzyme, Merck, Biogen and Roche, has been a member of advisory boards at Genzyme, Biogen, Merck and Novartis, has received sub-investigator fees from the ISS “Social Cognition in MS” project at Teva and sub-investigator fees from project CORFO 14PIE-26946 - InnoBioscience SpA. RUSM received academic travel support from Novartis, Genzyme, Merck, Biogen and Roche, has been a member of advisory boards at Genzyme, Biogen, Merck and Novartis. CC received academic travel support from Novartis, Genzyme, Merck, Biogen and Roche, has been a member of advisory boards at Genzyme, Biogen, Merck and Novartis, has received PI fees from the ISS “Social Cognition in MS” project at Teva, and PI fees from project CORFO 14PIE-26946 - InnoBioscience SpA.

References

    1. Brownlee W., Bourdette D., Broadley S., Killestein J., Ciccarelli O. Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic. Neurology. 2020 doi: 10.1212/WNL.0000000000009507. Apr 2pii: 10.1212/WNL.0000000000009507. - DOI - PubMed
    1. Carra, A., Steinberg, J., Macias-Islas, M.A., et al. COVID-19 EN PACIENTES CON ESCLEROSIS MÚLTIPLE RECOMENDACIONES LATINOAMERICANAS & SHARING INITIATIVE. 2020http://www.lactrimsweb.org/wp-content/uploads/2020/04/2020_04_09_RECOMEN....
    1. Costa-Frossard L., Moreno-Torres I., Meca-Lallana V., García-Domínguez J.M., En Representación Del Grupo de Estudio de Enfermedades Desmielinizantes de la Comunidad Autónoma de Madrid ERDGEEDCAM [EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic] Rev. Neurol. 2020;70(9):329–340. doi: 10.33588/rn.7009.2020155. May 1Review. Spanish. - DOI - PubMed
    1. Giovannoni G., Hawkes C., Lechner-Scott J., Levy M., Waubant E., Gold J. The COVID-19 pandemic and the use of MS disease-modifying therapies. Mult. Scler. Relat. Disord. 2020;39 doi: 10.1016/j.msard.2020.102073. Apr. - DOI - PMC - PubMed
    1. Sormani M.P., Italian Study Group on COVID-19 infection in multiple sclerosis An Italian programme for COVID-19 infection in multiple sclerosis. Lancet Neurol. 2020 doi: 10.1016/S1474-4422(20)30147-2. Apr 30pii: S1474-4422(20)30147-2. - DOI - PMC - PubMed

MeSH terms

Substances